Position
Researcher
Institution
The Rockefeller University
Linked Projects
Clinical Trial
Title: ANRS 176 RHIVIERA 02_Assessment of HIV remission upon ART interruption in individuals initiating ART in combination with two long lasting bNabs during primary infection
ART initiation during primary HIV infection limits the establishment, diversity and distribution of the viral reservoir while preserving key lymphoid organs of the deleterious effects of persistent viral replication and chronic immune activation, favoring the optimal maturation of immune responses. Early ART initiation may even facilitate long-term post-treatment control in some individuals. Therapeutic interventions during… Continue reading ANRS 176 RHIVIERA 02_Assessment of HIV remission upon ART interruption in individuals initiating ART in combination with two long lasting bNabs during primary infection
Country
France, USA
Starting year
2022
Duration
Members/PIs involved
Cécile Goujard
Clinician - Université Paris Sud, Bicêtre Hospital
Asier Sáez-Cirión
Researcher - Institut Pasteur
Laurence Meyer
Researcher - Université Paris-Saclay & APHP
Hugo Mouquet
Researcher - Institut Pasteur
Marina Caskey
Researcher - The Rockefeller University
Jean-Michel Molina
Clinician - Université de Paris INSERM
Michel Nussenzweig
Researcher - The Rockefeller University
Christel Protière
Researcher - INSERM (SESSTIM)
Véronique Avettand-Fènoël
Researcher - Medical virologist - Institut Cochin - CNRS 8104 / INSERM U1016 / Université Paris Cité
Hughes Fischer
Programme Coordinator - Act Up-Paris
